Maple Leaf Foods Reports Results for the Third Quarter 2014
-
Adjusted Operating Earnings(1)(3) for the third quarter was a loss of
$19.8 million (loss of$20.3 million last year) and$61.8 million for the nine months (loss of$80.4 million last year) -
Adjusted Earnings per Share(3)(4) for the quarter was a loss of
$0.13 (loss of$0.19 last year) and$0.49 for the nine months (loss of$0.66 last year) -
Net loss from continuing operations for the third quarter was
$26.7 million (loss of$24.5 million last year) and$190.8 million for the nine months (loss of$93.5 million last year) -
The Company ended production at its plant in
Moncton , leaving three remaining plants to close to complete its supply chain transformation
"We continue to make important advances towards our strategic goals,"
said
Financial Overview
Adjusted Operating Earnings for the third quarter was a loss of
Adjusted Earnings per Share was a loss of
Net loss from continuing operations for the third quarter was
For the first nine months, net loss from continuing operations was
Several items are excluded from the discussions of underlying earnings performance as they are not representative of ongoing operational activities. Refer to the section entitled Reconciliation of Non-IFRS Financial Measures at the end of this news release for a description and reconciliation of all non-IFRS financial measures.
Business Segment Review
Following is a summary of sales by business segment:
(Unaudited) | Third Quarter | Year-to-Date | |||||||||||
($ thousands) | 2014 | 2013 | 2014 | 2013 | |||||||||
Meat Products Group | $ | 814,699 | $ | 751,509 | $ | 2,345,651 | $ | 2,182,046 | |||||
Agribusiness Group(5) | 5,398 | 6,339 | 17,583 | 24,420 | |||||||||
Total Sales(3) | $ | 820,097 | $ | 757,848 | $ | 2,363,234 | $ | 2,206,466 |
The following table summarizes Adjusted Operating Earnings by business segment:
(Unaudited) | Third Quarter | Year-to-Date | ||||||||||
($ thousands) | 2014 | 2013 | 2014 | 2013 | ||||||||
Meat Products Group | $ | (18,220) | $ | (21,624) | $ | (61,312) | $ | (43,568) | ||||
Agribusiness Group | (1,610) | 1,559 | 3,252 | (28,255) | ||||||||
Protein Group | $ | (19,830) | $ | (20,065) | $ | (58,060) | $ | (71,823) | ||||
Non-Allocated Costs in Adjusted Operating Earnings(i) | — | (233) | (3,748) | (8,604) | ||||||||
Adjusted Operating Earnings(3) | $ | (19,830) | $ | (20,298) | $ | (61,808) | $ | (80,427) |
(i) | Non-allocated costs are comprised of expenses not separately identifiable to business segment groups, and do not form part of the measures used by the Company when assessing the segments' operating results. Non-allocated costs for 2013 have been re-stated on a comparable basis. |
Includes value-added prepared meats, lunch kits and snacks, and fresh pork, poultry and turkey products sold under leading Canadian brands such as Maple Leaf®, Schneiders® and many leading sub-brands.
Sales in the
For the first nine months, sales increased 7.5% to
Adjusted Operating Earnings for the third quarter improved to a loss of
The prepared meats business incurred transitional costs of approximately
For the first nine months, Adjusted Operating Earnings was a loss of
Includes Canadian hog production operations that primarily supply the
Adjusted Operating Earnings in the third quarter declined to a loss of
Other Matters
On
An investor presentation related to the Company's third quarter
financial results is available at www.mapleleaffoods.com and can be found under Investor Material on the Investors page. A conference call will be held at
A webcast presentation of the third quarter financial results will also
be available at:
http://www.media-server.com/m/p/ppaigon
The Company's full financial statements and related Management's Discussion and Analysis are available on the Company's website.
Reconciliation of Non-IFRS Financial Measures
Adjusted Operating Earnings
Adjusted Operating Earnings, a non-IFRS measure, is used by Management
to evaluate financial operating results. It is defined as earnings
before income taxes from continuing operations adjusted for items that
are not considered representative of ongoing operational activities of
the business and items where the economic impact of the transactions
will be reflected in earnings in future periods when the underlying
asset is sold or transferred. The table below provides a reconciliation
of net earnings as reported under IFRS in the unaudited consolidated
interim statements of earnings to Adjusted Operating Earnings for the
three and nine months ended, as indicated below. Management believes
that this basis is the most appropriate on which to evaluate operating
results, as they are representative of the ongoing operations of the
Company.
Three months ended September 30, 2014 | |||||||||||
($ thousands) (Unaudited) |
Meat Products Group |
Agribusiness Group |
Unallocated costs |
Consolidated | |||||||
Net earnings (loss) from continuing operations | $ | (26,671) | |||||||||
Income taxes | (8,011) | ||||||||||
Earnings (loss) before income taxes from continuing operations | $ | (34,682) | |||||||||
Interest expense and other financing costs | 2,500 | ||||||||||
Change in the fair value of non-designated interest rate swaps | (1,620) | ||||||||||
Other (income) expense | 458 | (621) | 5,617 | 5,454 | |||||||
Restructuring and other related costs | 7,016 | — | 7,271 | 14,287 | |||||||
Earnings (loss) from Continuing Operations | $ | (18,220) | $ | (1,610) | $ | 5,769 | $ | (14,061) | |||
Decrease (increase) in fair value of biological assets(2) | — | — | 15,363 | 15,363 | |||||||
Realized (gain) loss on commodity futures contracts(2) | — | — | (16,100) | (16,100) | |||||||
Unrealized (gain) loss on commodity futures contracts(2) | — | — | (5,032) | (5,032) | |||||||
Adjusted Operating Earnings(3) | $ | (18,220) | $ | (1,610) | $ | — | $ | (19,830) | |||
Three months ended September 30, 2013 | ||||||||||||
($ thousands) (Unaudited) |
Meat Products Group |
Agribusiness Group |
Unallocated costs |
Consolidated | ||||||||
Net earnings (loss) from continuing operations | $ | (24,474) | ||||||||||
Income taxes | (8,935) | |||||||||||
Earnings (loss) before income taxes from continuing operations | $ | (33,409) | ||||||||||
Interest expense | 18,746 | |||||||||||
Change in the fair value of non-designated interest rate swaps | (655) | |||||||||||
Other (income) expense | (2,030) | (141) | (17,029) | (19,200) | ||||||||
Restructuring and other related costs | 11,379 | — | — | 11,379 | ||||||||
Earnings (loss) from Continuing Operations | $ | (21,624) | $ | 1,559 | $ | (3,074) | $ | (23,139) | ||||
Decrease (increase) in fair value of biological assets(2) | — | — | (894) | (894) | ||||||||
Unrealized (gain) loss on commodity futures contracts(2) | — | — | 3,735 | 3,735 | ||||||||
Adjusted Operating Earnings(3) | $ | (21,624) | $ | 1,559 | $ | (233) | $ | (20,298) | ||||
Nine months ended September 30, 2014 | ||||||||||||
($ thousands) (Unaudited) |
Meat Products Group |
Agribusiness Group |
Unallocated costs |
Consolidated | ||||||||
Net earnings (loss) from continuing operations | $ | (190,821) | ||||||||||
Income taxes | (66,067) | |||||||||||
Earnings (loss) before income taxes from continuing operations | $ | (256,888) | ||||||||||
Interest expense and other financing costs | 128,243 | |||||||||||
Change in the fair value of non-designated interest rate swaps | (4,725) | |||||||||||
Other (income) expense | 985 | (1,075) | 8,184 | 8,094 | ||||||||
Restructuring and other related costs | 29,562 | — | 26,487 | 56,049 | ||||||||
Earnings (loss) from Continuing Operations | $ | (61,312) | $ | 3,252 | $ | (11,167) | $ | (69,227) | ||||
Decrease (increase) in fair value of biological assets(2) | — | — | (6,059) | (6,059) | ||||||||
Unrealized (gain) loss on commodity futures contracts(2) | — | — | 4,744 | 4,744 | ||||||||
Modification impact to long-term incentive plan(2) | — | — | 8,734 | 8,734 | ||||||||
Adjusted Operating Earnings(3) | $ | (61,312) | $ | 3,252 | $ | (3,748) | $ | (61,808) | ||||
Nine months ended September 30, 2013 | |||||||||||
($ thousands) (Unaudited) |
Meat Products Group |
Agribusiness Group |
Unallocated costs |
Consolidated | |||||||
Net earnings (loss) from continuing operations | $ | (93,483) | |||||||||
Income taxes | (38,868) | ||||||||||
Earnings (loss) before income taxes from continuing operations | $ | (132,351) | |||||||||
Interest expense and other financing costs | 51,394 | ||||||||||
Change in the fair value of non-designated interest rate swaps | (1,930) | ||||||||||
Other (income) expense | (46,913) | (709) | (20,951) | (68,573) | |||||||
Restructuring and other related costs | 60,976 | — | 1,745 | 62,721 | |||||||
Earnings (loss) from Continuing Operations | $ | (43,568) | $ | (28,255) | $ | (16,916) | $ | (88,739) | |||
Decrease (increase) in fair value of biological assets(2) | — | — | 4,569 | 4,569 | |||||||
Unrealized (gain) loss on commodity futures contracts(2) | — | — | 3,743 | 3,743 | |||||||
Adjusted Operating Earnings(3) | $ | (43,568) | $ | (28,255) | $ | (8,604) | $ | (80,427) | |||
Adjusted Earnings per Share
Adjusted Earnings per Share, a non-IFRS measure, is used by Management to evaluate ongoing financial operating results. It is defined as basic earnings per share from continuing operations attributable to common shareholders, and is adjusted for items that are not considered representative of ongoing operational activities of the business, and items where the economic impact of the transactions will be reflected in earnings in future periods when the underlying asset is sold or transferred. The table below provides a reconciliation of basic earnings per share from continuing operations as reported under IFRS in the unaudited consolidated interim statements of earnings to Adjusted Earnings per Share for the three and nine months ended, as indicated below. Management believes this basis is the most appropriate on which to evaluate financial results as they are representative of the ongoing operations of the Company.
($ per Share) (Unaudited) |
Three months ended September 30, |
Nine months ended September 30, |
|||||||||
2014 | 2013(i) | 2014 | 2013(i) | ||||||||
Basic earnings (loss) per share from continuing operations | $ | (0.19) | $ | (0.18) | $ | (1.35) | $ | (0.67) | |||
Restructuring and other related costs(ii) | 0.07 | 0.06 | 0.30 | 0.33 | |||||||
Items included in other income not considered representative of on-going operations(iii) | 0.02 | (0.08) | 0.04 | (0.35) | |||||||
Change in the fair value of non-designated interest rate swaps(iv) | (0.01) | — | (0.02) | (0.01) | |||||||
Change in the fair value of unrealized (gains) losses on commodity futures contracts(iv) | (0.03) | 0.02 | 0.02 | 0.02 | |||||||
Change in the fair value of realized (gains) losses on commodity futures contracts(iv) | (0.08) | — | — | — | |||||||
Change in the fair value of biological assets(iv) | 0.08 | (0.01) | (0.03) | 0.02 | |||||||
Other financing costs(v) | — | — | 0.51 | — | |||||||
Modification impact to long-term incentive plan(vi) | — | — | 0.05 | — | |||||||
Adjusted Earnings per Share(vii) | $ | (0.13) | $ | (0.19) | $ | (0.49) | $ | (0.66) |
(i) 2013 figures have been restated for the classification of the Rothsay
business and the
(ii) Includes per share impact of restructuring and other related costs, net
of tax and non-controlling interest.
(iii) Includes gains/losses associated with non-operational activities,
including gains/losses related to restructuring activities, business
combinations, discontinued operations, assets held for sale, and hedge
ineffectiveness recognized in earnings, all net of tax.
(iv) Includes per share impact of the change in fair value of non-designated
interest rate swaps, unrealized and realized (gains) losses on
commodity futures contracts and the change in fair value of biological
assets, net of tax.
(v) Includes a
(vi) Relates to a
(vii) May not add due to rounding.
Forward-Looking Statements
This document contains, and the Company's oral and written public communications often contain, "forward-looking information" within the meaning of applicable securities law. These statements are based on current expectations, estimates, forecasts, and projections about the industries in which the Company operates, as well as beliefs and assumptions made by the Management of the Company. Such statements include, but are not limited to, statements with respect to objectives and goals, in addition to statements with respect to beliefs, plans, objectives, expectations, anticipations, estimates, and intentions. Specific forward-looking information in this document includes, but is not limited to, statements with respect to: the anticipated benefits, timing, actions, costs, and investments associated with the Value Creation Plan; expectations regarding the use of derivatives, futures and options; expectations regarding improving efficiencies; the expected use of cash balances; source of funds for ongoing business requirements; capital investments and debt repayment; expectations regarding acquisitions and divestitures; the timing of new plant openings; old plant closures and job losses; LEED certification; expectations regarding the adoption of new accounting standards and the impact of such adoption on financial position; expectations regarding sufficiency of the allowance for uncollectible accounts; and expectations regarding pension plan performance and future pension plan liabilities and contributions. Words such as "expect", "anticipate", "intend", "may", "will", "plan", "believe", "seek", "estimate", and variations of such words and similar expressions are intended to identify such forward-looking information. These statements are not guarantees of future performance and involve assumptions and risks and uncertainties that are difficult to predict.
In addition, these statements and expectations concerning the performance of the Company's business in general are based on a number of factors and assumptions including, but not limited to: the condition of the Canadian, U.S., and Japanese economies; the rate of exchange of the Canadian dollar to the U.S. dollar, and the Japanese yen; the availability and prices of raw materials, energy and supplies; product pricing; the availability of insurance; the competitive environment and related market conditions; improvement of operating efficiencies whether as a result of the Value Creation Plan or otherwise; continued access to capital; the cost of compliance with environmental and health standards; no adverse results from ongoing litigation; no unexpected actions of domestic and foreign governments; and the general assumption that none of the risks identified below or elsewhere in this document will materialize. All of these assumptions have been derived from information currently available to the Company, including information obtained by the Company from third-party sources. These assumptions may prove to be incorrect in whole or in part. In addition, actual results may differ materially from those expressed, implied, or forecasted in such forward-looking information, which reflect the Company's expectations only as of the date hereof.
Factors that could cause actual results or outcomes to differ materially from the results expressed, implied, or forecasted by forward-looking information include, among other things:
-
risks associated with the Company's Transition Services Agreement with
Grupo Bimbo, S.A.B. de C.V . ofMexico
- risks associated with implementing and executing the Value Creation Plan;
- risks associated with the availability of capital;
- risks associated with changes in the Company's systems and processes;
- risks posed by food contamination, consumer liability, and product recalls;
- risks associated with acquisitions, divestitures, and capital expansion projects;
- impact on pension expense and funding requirements of fluctuations in the market prices of fixed income and equity securities and changes in interest rates;
- cyclical nature of the cost and supply of hogs and the competitive nature of the pork market generally;
- risks related to the health status of livestock;
- impact of a pandemic on the Company's operations;
- the Company's exposure to currency exchange risks;
- ability of the Company to hedge against the effect of commodity price changes through the use of commodity futures and options;
- impact of changes in the market value of the biological assets and hedging instruments;
- impact of international events on commodity prices and the free flow of goods;
- risks posed by compliance with extensive government regulation;
- risks posed by litigation;
- impact of changes in consumer tastes and buying patterns;
- impact of extensive environmental regulation and potential environmental liabilities;
- risks associated with a consolidating retail environment;
- risks posed by competition;
- risks associated with complying with differing employment laws and practices, the potential for work stoppages due to non-renewal of collective agreements, and recruiting and retaining qualified personnel;
- risks associated with pricing the Company's products;
- risks associated with managing the Company's supply chain; and
- risks associated with failing to identify and manage the strategic risks facing the Company.
The Company cautions the reader that the foregoing list of factors is
not exhaustive. These factors are discussed in more detail under the
heading "Risk Factors" presented previously in the 2013 Annual Report.
The reader should review such section in detail. Some of the
forward-looking information may be considered to be financial outlooks
for purposes of applicable securities legislation including, but not
limited to, statements concerning future EBITDA margins; capital
expenditures; cash costs; and non-cash restructuring charges. These
financial outlooks are presented to allow the Company to benchmark the
results of the Value Creation Plan. These financial outlooks may not be
appropriate for other purposes and readers should not assume they will
be achieved. The Company does not intend to, and the Company disclaims
any obligation to, update any forward-looking information, whether
written or oral, or whether as a result of new information, future
events or otherwise, except as required by law. Additional information
concerning the Company, including the Company's Annual Information
Form, is available on SEDAR at www.sedar.com.
Footnote Legend
- Adjusted Operating Earnings, a non-IFRS measure, is used by Management to evaluate financial operating results. It is defined as earnings from continuing operations adjusted for items that are not considered representative of ongoing operational activities of the business, and items where the economic impact of the transactions will be reflected in earnings in future periods when the underlying asset is sold or transferred. Please refer to the section entitled Reconciliation of Non-IFRS Financial Measures in this news release.
- Regarding biological assets, please refer to Note 7 of the Company's 2014 third quarter unaudited condensed consolidated interim financial statements. Realized and unrealized gains/losses on commodity futures contracts and settlement of long-term incentive plan are reported within cost of sales and selling, general and administrative respectively in the Company's 2014 third quarter unaudited condensed consolidated interim financial statements.
-
Figures exclude the results of the Rothsay business and the
Bakery Products Group , which are reported as discontinued operations. Refer to Note 22 of the Company's 2014 third quarter unaudited condensed consolidated interim financial statements. - Adjusted Earnings per Share, a non-IFRS measure, is used by Management to evaluate on-going financial operating results. It is defined as basic earnings per share from continuing operations attributable to common shareholders, and is adjusted for all items that are not considered representative of ongoing operational activities of the business, and items where the economic impact of the transactions will be reflected in earnings in future periods when the underlying asset is sold or transferred. Please refer to the section entitled Reconciliation of Non-IFRS Financial Measures in this news release.
- 2013 figures exclude the results of the Rothsay business, which are reported as discontinued operations. Refer to Note 22 of the Company's 2014 third quarter unaudited condensed consolidated interim financial statements.
- Unless otherwise stated, all per share amounts are basic attributable to common shareholders.
Condensed Consolidated Interim Financial Statements | |||||||||||||||
(Expressed in Canadian dollars) | |||||||||||||||
(Unaudited) | |||||||||||||||
MAPLE LEAF FOODS INC. | |||||||||||||||
Nine months ended September 30, 2014 and 2013 | |||||||||||||||
Consolidated Balance Sheets | |||||||||||||||
(In thousands of Canadian dollars) |
As at September 30, 2014 |
As at September 30, 2013 |
As at December 31, 2013 |
||||||||||||
(Unaudited) | (Unaudited) | ||||||||||||||
ASSETS | |||||||||||||||
Current assets | |||||||||||||||
Cash and cash equivalents | $ | 510,238 | $ | 400,306 | $ | 506,670 | |||||||||
Accounts receivable | 52,591 | 107,436 | 111,034 | ||||||||||||
Notes receivable | 120,818 | 124,005 | 115,514 | ||||||||||||
Inventories | 296,229 | 323,766 | 287,786 | ||||||||||||
Biological assets | 111,773 | 80,590 | 95,740 | ||||||||||||
Income and other taxes recoverable | 35,293 | 38,317 | 43,300 | ||||||||||||
Prepaid expenses and other assets | 14,396 | 21,808 | 17,921 | ||||||||||||
Assets held for sale | 634 | 110,838 | 5,206 | ||||||||||||
$ | 1,141,972 | $ | 1,207,066 | $ | 1,183,171 | ||||||||||
Property and equipment | 1,044,959 | 1,273,264 | 1,323,318 | ||||||||||||
Investment property | 3,191 | 13,011 | 12,865 | ||||||||||||
Employee benefits | 104,260 | 126,813 | 117,615 | ||||||||||||
Other long-term assets | 10,301 | 16,634 | 16,628 | ||||||||||||
Deferred tax asset | 701 | 113,958 | 26,119 | ||||||||||||
Goodwill | 428,236 | 725,545 | 720,798 | ||||||||||||
Intangible assets | 176,203 | 199,576 | 198,578 | ||||||||||||
Total assets | $ | 2,909,823 | $ | 3,675,867 | $ | 3,599,092 | |||||||||
LIABILITIES AND EQUITY | |||||||||||||||
Current liabilities | |||||||||||||||
Bank indebtedness | $ | - | $ | - | $ | 4,408 | |||||||||
Accounts payable and accruals | 313,652 | 597,101 | 649,554 | ||||||||||||
Provisions | 57,533 | 36,993 | 54,853 | ||||||||||||
Current portion of long-term debt | 330 | 641,306 | 209,780 | ||||||||||||
Other current liabilities | 20,103 | 15,999 | 47,927 | ||||||||||||
Liabilities associated with assets held for sale | - | 18,511 | - | ||||||||||||
$ | 391,618 | $ | 1,309,910 | $ | 966,522 | ||||||||||
Long-term debt | 9,948 | 892,433 | 744,212 | ||||||||||||
Employee benefits | 148,263 | 264,924 | 174,503 | ||||||||||||
Provisions | 19,051 | 37,226 | 19,603 | ||||||||||||
Other long-term liabilities | 21,942 | 57,632 | 28,744 | ||||||||||||
Deferred tax liability | 7,501 | 13,750 | 23,516 | ||||||||||||
Total liabilities | $ | 598,323 | $ | 2,575,875 | $ | 1,957,100 | |||||||||
Shareholders' equity | |||||||||||||||
Share capital | $ | 927,012 | $ | 902,986 | $ | 905,216 | |||||||||
Retained earnings | 1,307,453 | 47,148 | 602,717 | ||||||||||||
Contributed surplus | 89,244 | 91,172 | 79,139 | ||||||||||||
Accumulated other comprehensive income (loss) associated with continuing operations |
141 | (10,472) | (4,593) | ||||||||||||
Treasury stock | (12,350) | (1,350) | (1,350) | ||||||||||||
Total shareholders' equity | $ | 2,311,500 | $ | 1,029,484 | $ | 1,581,129 | |||||||||
Non-controlling interest | - | 70,508 | 60,863 | ||||||||||||
Total equity | $ | 2,311,500 | $ | 1,099,992 | $ | 1,641,992 | |||||||||
Total liabilities and equity | $ | 2,909,823 | $ | 3,675,867 | $ | 3,599,092 | |||||||||
Consolidated Statements of Net Earnings (Loss) | |||||||||||||||
(In thousands of Canadian dollars, except share amounts) | Three months ended September 30, | Nine months ended September 30, | |||||||||||||
(Unaudited) | 2014 | 2013 | 2014 | 2013 | |||||||||||
(Restated) |
(Restated) | ||||||||||||||
Sales | $ | 820,097 | $ | 757,848 | $ | 2,363,234 | $ | 2,206,466 | |||||||
Cost of goods sold | 759,972 | 707,347 | 2,195,850 | 2,067,910 | |||||||||||
Gross margin | $ | 60,125 | $ | 50,501 | $ | 167,384 | $ | 138,556 | |||||||
Selling, general and administrative expenses | 74,186 | 73,640 | 236,611 | 227,295 | |||||||||||
Loss from continuing operations before the following: | $ | (14,061) | $ | (23,139) | $ | (69,227) | $ | (88,739) | |||||||
Restructuring and other related costs | (14,287) | (11,379) | (56,049) | (62,721) | |||||||||||
Change in fair value of non-designated interest rate swaps | 1,620 | 655 | 4,725 | 1,930 | |||||||||||
Other (expense) income | (5,454) | 19,200 | (8,094) | 68,573 | |||||||||||
(Loss) earnings before interest and income taxes from continuing operations |
$ | (32,182) | $ | (14,663) | $ | (128,645) | $ | (80,957) | |||||||
Interest expense and other financing costs | 2,500 | 18,746 | 128,243 | 51,394 | |||||||||||
Loss before income taxes from continuing operations | $ | (34,682) | $ | (33,409) | $ | (256,888) | $ | (132,351) | |||||||
Income taxes | (8,011) | (8,935) | (66,067) | (38,868) | |||||||||||
Loss from continuing operations | $ | (26,671) | $ | (24,474) | $ | (190,821) | $ | (93,483) | |||||||
(Loss) earnings from discontinued operations | (96) | 39,995 | 930,915 | 94,272 | |||||||||||
Net (loss) earnings | $ | (26,767) | $ | 15,521 | $ | 740,094 | $ | 789 | |||||||
Attributed to: | |||||||||||||||
Common shareholders | $ | (26,767) | $ | 12,955 | $ | 738,119 | $ | (4,436) | |||||||
Non-controlling interest | - | 2,566 | 1,975 | 5,225 | |||||||||||
$ | (26,767) | $ | 15,521 | $ | 740,094 | $ | 789 | ||||||||
Earnings (loss) per share attributable to common shareholders: |
|||||||||||||||
Basic and diluted earnings (loss) per share | $ | (0.19) | $ | 0.09 | $ | 5.25 | $ | (0.03) | |||||||
Basic and diluted loss per share from continuing operations |
$ | (0.19) | $ | (0.18) | $ | (1.35) | $ | (0.67) | |||||||
Weighted average number of shares (millions) | 141.8 | 139.9 | 140.9 | 139.9 | |||||||||||
Consolidated Statements of Other Comprehensive Income | ||||||||||||||
(In thousands of Canadian dollars) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||
(Unaudited) | 2014 |
2013 |
2014 |
2013 |
||||||||||
(Restated) | (Restated) | |||||||||||||
Net (loss) earnings | $ | (26,767) | $ | 15,521 | $ | 740,094 | $ | 789 | ||||||
Other comprehensive income (loss) | ||||||||||||||
Items that will not be reclassified to profit or loss: | ||||||||||||||
Change in actuarial gains and losses (Net of tax of $1.6 million and $2.6 million; 2013: $8.5 million and $44.6 million) |
$ | (4,443) | $ | 24,365 | $ | (7,274) | $ | 128,706 | ||||||
Total items that will not be reclassified to profit or loss | $ | (4,443) | $ | 24,365 | $ | (7,274) | $ | 128,706 | ||||||
Items that are or may be reclassified subsequently to profit or loss: | ||||||||||||||
Change in accumulated foreign currency translation adjustment (Net of tax of nil) |
$ | (37) | $ | 65 | $ | (252) | $ | (154) | ||||||
Change in unrealized gains and losses on cash flow hedges (Net of tax of $1.5 million and $1.5 million; 2013: $0.3 million and $0.4 million) |
(4,049) | (980) | 4,187 | (1,127) | ||||||||||
Total items that are or may be reclassified subsequently to profit or loss |
$ | (4,086) | $ | (915) | $ | 3,935 | $ | (1,281) | ||||||
Other comprehensive income from continuing operations | $ | (8,529) | $ | 23,450 | $ | (3,339) | $ | 127,425 | ||||||
Other comprehensive income from discontinued operations(i) (Net of tax of $nil and $1.3 million; 2013: $0.1 million and $4.8 million) |
- | (104) | (569) | 18,476 | ||||||||||
Total other comprehensive income (loss) | $ | (8,529) | $ | 23,346 | $ | (3,908) | $ | 145,901 | ||||||
Comprehensive (loss) income | $ | (35,296) | $ | 38,867 | $ | 736,186 | $ | 146,690 | ||||||
Attributed to: | ||||||||||||||
Common shareholders | $ | (35,296) | $ | 36,288 | $ | 734,455 | $ | 139,454 | ||||||
Non-controlling interest | $ | - | $ | 2,579 | $ | 1,731 | $ | 7,236 |
(i) | The above amount includes $0.0 million for the three months ended September 30, 2014 (2013: $0.9 million) and $4.4 million for the nine months ended September 30, 2014 (2013: $13.8 million) relating to actuarial gains and losses that will not subsequently be re-classified to profit or loss. |
Consolidated Statements of Changes in Total Equity | ||||||||||||||||||||||||||
Attributable to Common Shareholders |
||||||||||||||||||||||||||
(In thousands of Canadian dollars) (Unaudited) |
Share capital |
Retained earnings |
Contributed surplus |
Total accumulated other comprehensive income (loss) associated with continuing operations |
Total accumulated other comprehensive income associated with assets held for sale |
Treasury stock |
Non- controlling interest |
Total equity |
||||||||||||||||||
Balance at December 31, 2013 | $ | 905,216 | $ | 602,717 | $ | 79,139 | $ | (4,593) | $ | - | $ | (1,350) | $ | 60,863 | $ | 1,641,992 | ||||||||||
Net earnings | 738,119 | - | - | - | - | 1,975 | 740,094 | |||||||||||||||||||
Re-classification to assets held for sale | - | - | - | 799 | (799) | - | - | - | ||||||||||||||||||
Other comprehensive income (loss) | - | (10,488) | - | 3,935 | 2,889 | (244) | (3,908) | |||||||||||||||||||
Dividends declared ($0.12 per share) | - | (16,951) | - | - | - | - | (3,017) | (19,968) | ||||||||||||||||||
Stock-based compensation expense | - | - | 26,117 | - | - | - | - | 26,117 | ||||||||||||||||||
Disposal of business | - | - | - | - | (2,090) | - | (59,577) | (61,667) | ||||||||||||||||||
Exercise of stock options | 21,796 | - | - | - | - | - | - | 21,796 | ||||||||||||||||||
Shares purchased by RSU trust | - | - | - | - | - | (11,000) | - | (11,000) | ||||||||||||||||||
Modification of stock compensation plan | - | (5,944) | (16,012) | - | - | - | - | (21,956) | ||||||||||||||||||
Balance at September 30, 2014 | $ | 927,012 | $ | 1,307,453 | $ | 89,244 | $ | 141 | $ | - | $ | (12,350) | $ | - | $ | 2,311,500 | ||||||||||
Attributable to Common Shareholders |
||||||||||||||||||||||||||
(In thousands of Canadian dollars) (Unaudited) |
Share capital |
Retained deficit |
Contributed surplus |
Total accumulated other comprehensive loss associated with continuing operations |
Total accumulated other comprehensive income associated with assets held for sale |
Treasury stock |
Non- controlling interest |
Total equity |
||||||||||||||||||
Balance at December 31, 2012 | $ | 902,810 | $ | (72,701) | $ | 75,913 | $ | (13,263) | $ | - | $ | (1,845) | $ | 67,085 | $ | 957,999 | ||||||||||
Net earnings (loss) | - | (4,436) | - | - | - | - | 5,225 | 789 | ||||||||||||||||||
Other comprehensive income (loss) | - | 141,099 | - | 2,791 | - | - | 2,011 | 145,901 | ||||||||||||||||||
Dividends declared ($0.12 per share) | - | (16,814) | - | - | - | - | (3,813) | (20,627) | ||||||||||||||||||
Stock-based compensation expense | - | - | 10,246 | - | - | - | - | 10,246 | ||||||||||||||||||
Exercise of stock options | 176 | - | - | - | - | - | - | 176 | ||||||||||||||||||
Issuance of treasury stock | - | - | (495) | - | - | 495 | - | - | ||||||||||||||||||
Modification of stock compensation plan | - | - | 3,508 | - | - | - | - | 3,508 | ||||||||||||||||||
Other | - | - | 2,000 | - | - | - | - | 2,000 | ||||||||||||||||||
Balance at September 30, 2013 | $ | 902,986 | $ | 47,148 | $ | 91,172 | $ | (10,472) | $ | - | $ | (1,350) | $ | 70,508 | $ | 1,099,992 | ||||||||||
Consolidated Statements of Cash Flow | ||||||||||||||||
(In thousands of Canadian dollars) | Three months ended September 30, | Nine months ended September 30, | ||||||||||||||
(Unaudited) | 2014 | 2013 | 2014 | 2013 | ||||||||||||
CASH (USED IN) PROVIDED BY: | ||||||||||||||||
Operating activities | ||||||||||||||||
Net (loss) earnings | $ | (26,767) | $ | 15,521 | $ | 740,094 | $ | 789 | ||||||||
Add (deduct) items not affecting cash: | ||||||||||||||||
Change in fair value of biological assets | 15,363 | (894) | (6,059) | 4,569 | ||||||||||||
Depreciation and amortization | 29,776 | 35,867 | 80,069 | 105,136 | ||||||||||||
Stock-based compensation | 6,250 | (515) | 26,117 | 10,246 | ||||||||||||
Deferred income taxes | (9,152) | (1,275) | 31,287 | (23,457) | ||||||||||||
Income tax current | 1,126 | 7,725 | 11,069 | 19,696 | ||||||||||||
Interest expense and other financing costs | 2,500 | 18,715 | 129,029 | 52,051 | ||||||||||||
Loss (gain) on sale of long-term assets | 222 | (1,452) | 384 | (3,256) | ||||||||||||
Loss (gain) on sale of business | 111 | - | (1,007,465) | - | ||||||||||||
Gain on sale of assets held for sale | - | (11,520) | (1,736) | (57,076) | ||||||||||||
Change in fair value of non-designated interest rate swaps | (1,620) | (655) | (4,725) | (1,930) | ||||||||||||
Change in fair value of derivative financial instruments | (7,953) | 2,353 | 2,656 | 3,863 | ||||||||||||
Impairment of assets (net of reversals) | 889 | 115 | 1,674 | 5,924 | ||||||||||||
Increase in pension liability | 6,265 | 2,081 | 12,646 | 14,710 | ||||||||||||
Net income taxes paid | (112) | (8,941) | (8,727) | (20,978) | ||||||||||||
Net settlement of financial instruments | - | - | (23,631) | - | ||||||||||||
Early repayment premium | - | - | (76,311) | - | ||||||||||||
Interest paid | (2,399) | (17,656) | (41,362) | (49,470) | ||||||||||||
Change in provision for restructuring and other related costs | 1,012 | 5,955 | 31,269 | 47,906 | ||||||||||||
Other | (4,841) | (9,191) | (32,810) | (19,391) | ||||||||||||
Change in non-cash operating working capital | 20,759 | 82,145 | (241,251) | 123,719 | ||||||||||||
Cash (used in) provided by operating activities | $ | 31,429 | $ | 118,378 | $ | (377,783) | $ | 213,051 | ||||||||
Financing activities | ||||||||||||||||
Dividends paid | $ | (5,680) | $ | (5,620) | $ | (16,951) | $ | (16,814) | ||||||||
Dividends paid to non-controlling interest | - | (1,271) | (24,621) | (3,813) | ||||||||||||
Net increase (decrease) in long-term debt | (125) | 1,418 | (699,139) | 910 | ||||||||||||
Net drawings (payments) on the credit facility | - | 198,000 | (255,000) | 312,000 | ||||||||||||
Exercise of stock options | 4,124 | - | 21,796 | 176 | ||||||||||||
Payment of financing fees | - | - | (3,769) | - | ||||||||||||
Other | - | (293) | - | - | ||||||||||||
Cash (used in) provided by financing activities | $ | (1,681) | $ | 192,234 | $ | (977,684) | $ | 292,459 | ||||||||
Investing activities | ||||||||||||||||
Additions to long-term assets | $ | (48,015) | $ | (108,076) | $ | (223,946) | $ | (273,508) | ||||||||
Acquisition of business | - | - | - | (922) | ||||||||||||
Capitalization of interest expense | - | (3,931) | (5,504) | (11,126) | ||||||||||||
Adjustment to sale of business | - | - | (468) | - | ||||||||||||
Proceeds from sale of business | - | - | 1,647,015 | - | ||||||||||||
Transaction costs | (111) | - | (29,012) | - | ||||||||||||
Cash associated with divested business | - | - | (23,011) | - | ||||||||||||
Proceeds from sale of long-term assets | 6 | 2,030 | 3,261 | 8,496 | ||||||||||||
Proceeds from sale of assets held for sale | - | 61,748 | 6,108 | 129,685 | ||||||||||||
Purchase of treasury stock | (11,000) | - | (11,000) | - | ||||||||||||
Cash provided by (used in) investing activities | $ | (59,120) | $ | (48,229) | $ | 1,363,443 | $ | (147,375) | ||||||||
Increase (decrease) in cash and cash equivalents | $ | (29,372) | $ | 262,383 | $ | 7,976 | $ | 358,135 | ||||||||
Net cash and cash equivalents, beginning of period | 539,610 | 137,923 | 502,262 | 42,171 | ||||||||||||
Net cash and cash equivalents, end of period | $ | 510,238 | $ | 400,306 | $ | 510,238 | $ | 400,306 | ||||||||
Segmented Financial Information | ||||||||||||||
Three months ended September 30, |
Nine months ended September 30, | |||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||
(Restated) |
(Restated) | |||||||||||||
Sales | ||||||||||||||
Meat Products Group | $ | 814,699 | $ | 751,509 | $ | 2,345,651 | $ | 2,182,046 | ||||||
Agribusiness Group(i) | 5,398 | 75,687 | 17,583 | 212,896 | ||||||||||
Bakery Products Group(i) | - | 392,593 | 567,861 | 1,159,188 | ||||||||||
Total sales | $ | 820,097 | $ | 1,219,789 | $ | 2,931,095 | $ | 3,554,130 | ||||||
Sales from discontinued operations | - | (461,941) | (567,861) | (1,347,664) | ||||||||||
Sales from continuing operations | $ | 820,097 | $ | 757,848 | $ | 2,363,234 | $ | 2,206,466 | ||||||
Earnings before restructuring and other related costs and other income |
||||||||||||||
Meat Products Group | $ | (18,220) | $ | (21,624) | $ | (61,312) | $ | (43,568) | ||||||
Agribusiness Group(i) | (1,610) | 22,562 | 3,252 | 29,668 | ||||||||||
Bakery Products Group(i) | - | 38,900 | 47,829 | 92,460 | ||||||||||
Non-allocated costs | 5,769 | (3,074) | (11,167) | (16,916) | ||||||||||
Total earnings before restructuring and other related costs and other income |
$ | (14,061) | $ | 36,764 | $ | (21,398) | $ | 61,644 | ||||||
Earnings before restructuring and other related costs and other income from discontinued operations |
- | (59,903) | (47,829) | (150,383) | ||||||||||
Earnings before restructuring and other related costs and other income from continuing operations |
$ | (14,061) | $ | (23,139) | $ | (69,227) | $ | (88,739) | ||||||
Capital expenditures | ||||||||||||||
Meat Products Group | $ | 38,865 | $ | 92,257 | $ | 179,488 | $ | 231,463 | ||||||
Agribusiness Group(i) | 2,813 | 3,591 | 4,782 | 11,436 | ||||||||||
Bakery Products Group(i) | - | 12,228 | 17,789 | 30,609 | ||||||||||
$ | 41,678 | $ | 108,076 | $ | 202,059 | $ | 273,508 | |||||||
Depreciation and amortization | ||||||||||||||
Meat Products Group | $ | 22,774 | $ | 17,428 | $ | 60,961 | $ | 49,847 | ||||||
Agribusiness Group(i) | 1,693 | 4,043 | 4,117 | 12,295 | ||||||||||
Unallocated(ii) | 5,309 | - | 9,849 | - | ||||||||||
Bakery Products Group(i) | - | 14,396 | 5,142 | 42,994 | ||||||||||
$ | 29,776 | $ | 35,867 | $ | 80,069 | $ | 105,136 |
(i) | The prior year results of the animal by-product recycling operations, Fresh Pasta and Sauces businesses and Canada Bread are included in the comparative results of the Agribusiness Group and Bakery Products Group respectively. |
(ii) | Includes depreciation on assets used to service divested business. |
As at September 30, 2014 |
As at September 30, 2013 |
As at December 31, 2013 | |||||||||||||
Total assets | |||||||||||||||
Meat Products Group | $ | 2,031,004 | $ | 1,798,777 | $ | 1,823,866 | |||||||||
Agribusiness Group(i) | 205,083 | 282,061 | 195,537 | ||||||||||||
Bakery Products Group(i) | - | 1,014,807 | 1,169,669 | ||||||||||||
Non-allocated assets | 673,736 | 580,222 | 410,020 | ||||||||||||
$ | 2,909,823 | $ | 3,675,867 | $ | 3,599,092 | ||||||||||
Goodwill | |||||||||||||||
Meat Products Group | $ | 428,236 | $ | 428,235 | $ | 428,236 | |||||||||
Bakery Products Group(i) | - | 297,310 | 292,562 | ||||||||||||
$ | 428,236 | $ | 725,545 | $ | 720,798 |
(i) | The prior year results as at September 30, 2013 of the Agribusiness Group and Bakery Products Group include assets and goodwill from the animal by-product recycling operations, Fresh Pasta and Sauces, and Canada Bread businesses, respectively. |
SOURCE
Investor Contact: Nick Boland
VP Investor Relations: 416-926-2005
Media Contact: 416-926-2020